400
Participants
Start Date
November 30, 2010
Primary Completion Date
August 31, 2011
Study Completion Date
August 31, 2011
dapagliflozin
2.5 mg tablet, taken orally, twice daily
dapagliflozin
5 mg tablet taken orally, twice daily
dapagliflozin
10 mg tablet taken orally, once daily
metformin
\>/= 1500 mg total daily dose, tablets taken orally, twice daily
placebo
placebo
Research Site, Aßlar
Research Site, Berlin
Research Site, Biberach A.d. Riss
Research Site, Bosenheim
Research Site, Dippoldiswalde
Research Site, Falkensee
Research Site, Meissen
Research Site, München
Research Site, Neuwied
Research Site, Pirna
Research Site, Wahlstedt
Research Site, Balatonfüred
Research Site, Budapest
Research Site, Csongrád
Research Site, Debrecen
Research Site, Gyöngyös
Research Site, Kecskemét
Research Site, Makó
Research Site, Nyíregyháza
Research Site, Tát
Research Site, Zalaegerszeg
Research Site, Brasov
Research Site, Bucharest
Research Site, Iași
Research Site, Sibiu
Research Site, Suceava
Research Site, Banská Bystrica
Research Site, Bratislava
Research Site, Dolný Kubín
Research Site, Košice
Research Site, Lučenec
Research Site, Námestovo
Research Site, Piešťany
Research Site, Prievidza
Research Site, Rimavská Sobota
Research Site, Ružomberok
Research Site, Žilina
Research Site, Verulam
Research Site, Cape Town
Research Site, Durban
Research Site, eMkhomazi
Research Site, Johannesburg
Research Site, Durban
Research Site, Chur
Research Site, Basel
Research Site, Bern
Research Site, Geneva
Research Site, Kreuzlingen
Research Site, Lugano
Research Site, Rorschach
Research Site, Vynnitsa
Research Site, Zaporizhzhya
Research Site, Dnipropetrov'sk
Research Site, Kiev
Research Site, Vinnytsia
Lead Sponsor
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
AstraZeneca
INDUSTRY